Mulberry leaf polyphenols possess antiatherogenesis effect via inhibiting LDL oxidation and foam cell formation

Mon-Yuan Yang1, Chien-Ning Huang, Kuei-Chuan Chan

  • 1Institute of Biochemistry and Biotechnology, Chung-Shan Medical University, Number 110, Section 1, Chien-Kuo North Road, Taichung 402, Taiwan.

Insights

Mulberry leaf extracts show anti-atherogenic effects by inhibiting oxidized LDL. Polyphenolic extracts (MLPE) were more potent, reducing foam cell formation and regulating ox-LDL uptake in macrophages.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Nutraceuticals

Background:

  • Atherogenesis is characterized by oxidized low-density lipoprotein (ox-LDL) uptake by macrophages.
  • Mulberry leaf extracts (MLE) and their polyphenolic constituents (MLPE) are investigated for potential therapeutic benefits.

Purpose of the Study:

  • To evaluate the anti-atherogenic effects of MLE and MLPE.
  • To compare the potency of MLE and MLPE in inhibiting ox-LDL-induced cellular damage and foam cell formation.

Main Methods:

  • Assessing the inhibition of LDL oxidation and lipid peroxidation by MLE and MLPE.
  • Measuring reactive oxygen species (ROS) generation and antioxidant enzyme activity (SOD-1, GPx) in macrophages.
  • Quantifying foam cell formation and the expression of key scavenger receptors (PPARγ, CD36, SR-A).

Main Results:

  • Both MLE and MLPE inhibited LDL oxidation and lipid peroxidation, with MLPE demonstrating greater potency.
  • MLPE significantly reduced ROS generation and enhanced SOD-1 and GPx levels in macrophages more effectively than MLE.
  • MLPE showed 1.5-fold higher potency in decreasing foam cell formation compared to MLE at equivalent doses.
  • MLE and MLPE downregulated the expression of PPARγ, CD36, and SR-A, indicating modulation of ox-LDL uptake pathways.

Conclusions:

  • Mulberry leaf extracts, particularly the polyphenolic fraction (MLPE), exhibit significant anti-atherogenic properties.
  • MLPE demonstrates superior efficacy in mitigating ox-LDL-induced cellular damage and foam cell formation.
  • MLPE warrants further investigation as a potential therapeutic agent for preventing atherosclerosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...